Replication-competent herpes simplex viral vectors for cancer therapy

Advances in Virus Research

Volumn 55, Issue , 2000, Pages 409-424

  Markovitz, Nancy S ^a   Roizman, Bernard ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BRAIN TUMOR; GENE THERAPY; GENE VECTOR; GENETIC ENGINEERING; GENETICS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; METHODOLOGY; MOUSE; PHYSIOLOGY; REVIEW; VIRUS REPLICATION;

ANIMALS; BRAIN NEOPLASMS; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; MICE; VIRUS REPLICATION;

EID: 0034573432     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/s0065-3527(00)55010-6     Document Type: Review

References (79)

1. R.J Whitley Herpes simplex viruses B.N Fields D.M Knipe P.M Howley Fields Virology 3rd Ed. 1996 Lippincott-Raven Publishers Philadelphia 2297 2342
2. D.T Fleming G.M McQuillan R.E Johnson A.J Nahmias S.O Aral F.K Lee M.E St. Louis Herpes simplex virus type 2 in the United States, 1976 to 1994 N. Engl. J. Med. 337 1997 1105 1111
3. V.A Levine S.A Leibel P.H Gutin Neoplasms of the central nervous system V.T Devita S Hellman S.A Rosenberg Cancer: Principles and Practice of Oncology 1997 Lippincott-Raven Publishers Philadelphia 2022 2082
4. D.J McGeoch A Dolan S Donald F.J Rixon Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1 J. Mol. Biol. 181 1985 1 13
5. D.J McGeoch A Dolan S Donald D.H Brauer Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1 Nucleic Acids Res. 14 1986 1727 1745
6. D.J McGeoch M.A Dalrymple A.J Davison A Dolan M.C Frame D McNab L.J Perry J.E Scott P Taylor The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1 J. Gen. Virol. 69 1988 1531 1574
7. L.J Perry D.J McGeoch The DNA sequences of the long repeat region and adjoining parts of the long unique region in the genome of herpes simplex virus type 1 J. Gen. Virol. 69 1988 2831 2846
8. A Dolan E McKie A.R MacLean D.J McGeoch Status of the ICP34.5 gene in herpes simplex virus type 1 strain 17 J. Gen. Virol. 73 1992 971 973
9. A Dolan F.F Jamieson C Cunningham B.C Barnett D.J McGeoch The genome sequence of herpes simplex virus type 2 J. Virol. 72 1998 2010 2021
10. B Roizman A.E Sears Herpes simplex viruses and their replication B.N Fields D.M Knipe P.M Howley Fields Virology 3rd Ed. 1996 Lippincott-Raven Publishers Philadelphia 2231 2342
11. B Roizman The function of herpes simplex virus genes: A primer for genetic engineering of novel vectors 3rd edition Proc. Natl. Acad. Sci. U.S.A. 93 1996 11307 11312
12. R.I Montgomery M.S Warner B.J Lum P.G Spear Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family Cell 87 1996 427 436
13. J.C Whitbeck C Peng H Lou R Xu S.H Willis M Ponce de Leon T Peng A.V Nicola R.I Montgomery M.S Warner A.M Doouliks L.A Spruce W.T Moore J.D Lambris P.G Spear G.H Cohen R.J Eisenberg Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry J. Virol. 71 1997 6083 6093
14. F Cocchi L Menotti P Mirandola M Lopez G Campadelli-Fiume The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cells J. Virol. 72 1998 9992 10002
15. R.J Geraghty J.C Krummenacher G.H Cohen R.J Eisenberg P.G Spear Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor Science 280 1998 1618 1620
16. M.S Warner R.J Geraghty W.M Martinez R.I Montgomery J.C Whitbeck R.L Xu R.J Eisenberg G.H Cohen P.G Spear A cell surface protein with herpes virus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus 1, herpes simplex virus 2 and pseudorabies virus Virology 246 1998 179 189
17. J.G Stevens E.K Wagner G.B Devi-Rao M.L Cook L.T Feldman RNA complementary to a herpesvirus α gene mRNA is prominent in latently infected neurons Science 235 1987 1056 1059
18. L.E Post B Roizman A generalized technique for deletion of specific genes in large genomes: a Gene 22 of herpes simplex virus 1 is not essential for growth Cell 25 1981 227 232
19. B Roizman F.J Jenkins Genetic engineering of novel genomes of large DNA viruses Science 129 1985 1208 1218
20. M van Zijl W Quint J Briaire T de Rover A Gielkens A Berns Regeneration of herpesviruses from molecularly cloned subgenomic fragments J. Virol. 62 1988 2191 2195
21. B.C Horsburgh M.M Hubinette F Tufaro Genetic manipulation of herpes simplex virus using bacterial artificial chromosomes Methods Enzymol. 306 1999 337 352
22. W Brune C Menard U Hobom S Odenbreit M Messerle U.H Koszinowski Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis Nature Tech. 17 1999 360 364
23. S.A Andreansky B He G.Y Gillespie L Soroceanu J.M Markert J Chou B Roizman R.J Whitley The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors 3rd edition Proc. Natl. Acad. Sci. U.S.A. 93 1996 11313 11318
24. R.B Pyles R.E Warnwick C.L Chalk B.E Szanti L.M Parysek A novel multiply-mutated HSV 1 strain for the treatment of human brain tumors Hum. Gene Ther. 8 1997 533 544
25. E Pelosi E Rozenberg D.M Coen K.L Tyler A herpes simplex virus DNA polymerase mutation that specifically attenuates neurovirulence in mice Virology 252 1998 364 372
26. A.E Sears I.W Halliburton B Meignier S Silver B Roizman Herpes simplex virus 1 mutant deleted in the α22 gene: Growth and gene expression in permissive and restrictive cells and establishment of latency in mice J. Virol. 55 1985 338 346
27. S.J Advani G.S Sibley P.Y Song D.E Hallahan Y Kataoka B Roizman R.R Weichselbaum Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: A new paradigm for destruction of therapeutically intractable tumors Gene Ther. 5 1998 160 165
28. J Markert A Malick D.M Coen R.L Martuza Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir Neurosurgery 32 1993 597 603
29. L between 0 and 0.02 and 0.81 to 0.83 map units is non-neurovirulent for mice J. Gen. Virol. 70 1989 705 716
30. A.R MacLean M Ul-Fareed L Robertson J Harland S.M Brown Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17 + between immediate early gene 1 and the ‘a’ sequence J. Gen. Virol. 72 1991 631 639
31. C.M Kramm M Chase U Herrlinger A Jacobs P.A Pechan N.G Rainov M Sena-Esteves M Aghi F.H Barnett E.A Chiocca X.O Breakefield Therapeutic efficacy and safety of a second generation replication-conditional HSV1 vector for brain tumor gene therapy Hum. Gene Ther. 8 1997 2057 2068
32. R.Y Chung Y Saeki E.A Chiocca B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells J. Virol. 73 1999 7556 7564
33. 134.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programmed cell death in neuronal cells 3rd edition Proc. Natl. Acad. Sci. U.S.A. 89 1992 3266 3270
34. 134.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage 3rd edition Proc. Nail. Acad. Sci. U.S.A. 91 1994 5247 5251
35. 1134.5- mutants of herpes simplex virus 1 3rd edition Proc. Natl. Acad. Sci. U.S.A. 92 1995 10516 10520
36. 134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1α to dephosphorylate the a subunit of the eIF-2 translation initiation factor and preclude the shutoff of protein synthesis by double stranded RNA activated protein kinase (PER) 3rd edition Proc. Natl. Acad. Sci. U.S.A. 94 1997 843 848
37. 13.45 protein of herpes simplex virus 1 has the structural and functional attributes of a protein phosphatase 1 regulatory subunit and is present in a high molecular weight complex with the enzyme in infected cells J. Biol. Chem. 273 1998 20737 20743
38. 1 134.5, a gene nonessential for growth in culture Science 250 1990 1262 1266
39. 134.5 deletion mutants in rodent models J. Clin. Invest. 91 1993 2837 2843
40. D.A Leib T.E Harrison K.M Laslo M.A Machalek N.J Moorman H.W Virgin Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo J. Exp. Med. 189 1999 663 672
41. T Mineta S.D Rabkin R.L Martuza Experimental therapy for malignant brain tumors using genetically engineered herpes simplex virus type 1 M Nagai Brain Tumor: Research and Therapy 1996 Springer Verlag New York 409 414
42. M.A Spear U Herrlinger N Rainov P Pechan R Weissleder X.O Breakefield Targeting gene therapy vectors to CNS malignancies J. Neurovirol. 4 1998 133 147
43. R.L Martuza Act locally, think globally Nat. Med. 3 1997 1323
44. J.M Markert D.M Coen A Malick T Mineta R.L Martuza Expanded spectrum of viral therapy for the treatment of nervous system tumors J. Neurosurg. 77 1992 590 594
45. S Andreansky L Soroceanu E.R Flotte J Chou J.M Markert G.Y Gillespie B Roizman R.J Whitley Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors Cancer Res. 576 1997 1502 1509
46. T Mineta S.D Rabkin T Yazaki W.D Hunter R.L Martuza Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas Nature Med. 1 1995 938 943
47. B.P Randazzo M.G Bhat S Kesari N.W Fraser S.M Brown Treatment of experimental subcutaneous human melanoma with a replicationrestricted herpes simplex virus mutant J. Invest. Dermatol. 108 1997 933 937
48. T Mineta S.D Rabkin R.L Martuza Treatment of malignant gliomas using gancyclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant Cancer Res. 54 1994 3963 3966
49. T Yazaki H.J Manz S.D Rabkin R.L Martuza Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1 Cancer Res. 55 1995 4752 4756
50. M Toda R.L Martuza H Kojima S.D Rabkin In situ cancer vaccination: An IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity J. Immunol. 160 1998 4457 4464
51. M Toda S.D Rabkin H Kojima R.L Martuza Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity Hum. Gene Ther. 10 1999 385 393
52. R.L Martuza A Malick J.M Markert K.L Ruffner D.M Coen Experimental therapy of human ghoma by means of a genetically engineered virus mutant Science 252 1991 854 856
53. T.M Lasner S Kesari M Brown V.M.-Y Lee N.W Fraser J.Q Trojanowski Therapy of murine model of pediatric brain tumors using a herpes simplex virus type-1 ICP34.5 mutant and demonstration of viral replication within the CNS J. Neuropathol. Exp. Neural. 55 1996 1259 1269
54. S Kesari B.P Randazzo T Valyi-Nagy Q.S Huang S.M Brown A.R MacLean V.M.-Y Lee J.Q Trojanowski N.W Fraser Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant Lab. Invest. 73 1995 636 648
55. B.P Randazzo S Kesari R.M Gesser D Alsop J.C Ford S.M Brown A MacLean N.W Fraser Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant Virology 211 1995 94 101
56. 134.5- mutant of herpes simplex virus 1 J. Virol. 71 1997 5560 5569
57. S Kesari T.M Lasner K.R Balsara B.P Randazzo V.M Lee J.Q Trojanowski N.W Fraser A neuroattenuated ICP34.5-deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous system J. Gen. Viral. 79 1998 525 536
58. E.A McKie S.M Brown A.R MacLean D.I Graham Histopathological responses in the CNS following inoculation with a non-neurovirulent mutant (1716) of herpes simplex virus type 1 (HSV 1): Relevance for gene and cancer therapy Neuropathol. Appl. Neurobiol. 24 1998 367 372
59. I Mohr Y Gluzman A herpes virus genetic element which affects translation in the absence of viral GADD34 function EMBO J. 15 1996 4759 4766
60. B He J Chou R Brandimarti I Mohr Y Gluzman B Roizman Suppression of the phenotype of γ.34.5- herpes simplex virus 1: Failure of activated RNA-dependent protein kinase to shut off protein synthesis is associated with a deletion in the domain of the α47 gene J. Virol. 71 1997 6049 6054
61. R Rampling G Cruickshank A MacLean M Brown Therapeutic replication-competent herpes virus Nat. Med. 4 1998 133
62. W.D Hunter R.L Martuza F Feigenbaum T Todo T Mineta T Yazaki M Toda J.T Newsome R.C Platenberg H.J Manz S.D Rabkin Attenuated, replication-competent herpes simplex virus type 1 mutant G207: Safety evaluation of intracerebral injection in nonhuman primates J. Viral. 73 1999 6319 6326
63. J Markert M Medlock G.Y Gillespie F Feigenbaum T Todo S Rabkin W Hunter F Tufaro R.L Martuza Preliminary report on the use of a genetically-engineered HSV 1 in the treatment of malignant glioma in humans 24th International Herpesvirus Workshop 13.021 1999 (Abstract)
64. N.G Rainov K.U Dobberstein U Dorant M Chase C.M Kramm E.A Chiocca X.O Breakefield Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex Virus vectors Cancer Gene Ther. 5 1998 158 162
65. F.H Barnett N.G Rainov K Ikeda D.E Schuback P Elliott C.M Kramm M Chase N.H Qureshi G Harsh 4th E.A Chiocca X.O Breakefield Selective delivery of herpes virus vectors to experimental brain tumors using RMP-7 Cancer Gene Ther. 6 1999 14 20
66. C.J Wikstrand R.E McLendon A.H Friedman D.D Bigner Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII Cancer. Res. 57 1997 4130 4140
67. C.J Wikstrand C.J Reist G.E Archer M.R Zalutsky D.D Bigner The class III variant of the epidermal growth factor receptor (EGFRvIII): Characterization and utilization as an immunotherapeutic target J. Neurovirol. 4 1998 148 158
68. M.E Fotaki J.R Pink J Mous Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transfer Gene Ther 4 1997 901 908
69. S.A Andreansky B He J van Cott J.M Markert G.Y Gillespie B Roizman Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins Gene Ther. 5 1998 121 130
70. T Oligino P.L Poliani Y Wang S.Y Tsai B.W O'Malley D.J Fink J.C Glorioso Drug inducible transgene expression in brain using a herpes simplex Virus vectors Gene Ther. 5 1998 491 496
71. M.B Guffey W.S Luckett G.Y Gillespie R.J Whitley J.M Markert Genetically engineered HSV 1 expressing bacterial cytosine deaminase for experimental murine brain tumor therapy 24th International Herpesvirus Workshop 13.020 1999 (Abstract)
72. F Yao E Eriksson A novel tetracycline-inducible viral replication switch Hum. Gene Ther. 10 1999 419 427
73. S.-I Miyatake A Iyer R.L Martuza S.D Rabkin Transcriptional targeting of herpes simplex virus for cell-specific replication J. Virol. 71 1997 5124 5132
74. E.A McKie D.L Graham S.M Brown Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector-potential glioblastoma targeting Gene Ther. 5 1998 440 450
75. J.D Bradley Y Kataoka S Advani S.M Chung R.B Arani G.Y Gillespie R.J Whitley J.M Markert B Roizman R.R Weichselbaum Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus Clin. Cancer Res. 5 1999 1517 1522
76. M Chase R.Y Chung E.A Chiocca An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapy Nature Biotech. 16 1998 444 448
77. N.G Rainov M Sena-Esteves C Fraefel K.U Dobberstein E.A Chiocca X.O Breakefield A chimeric fusion protein of cytochrome CYP4B1 and green fluorescent protein for detection of pro-drug activating gene delivery and for gene therapy in malignant glioma Adv. Exp. Med. Biol. 451 1998 393 403
78. T Valyi-Nagy M.U Fareed J.S O'Keefe R.M Gesser A.R MacLean S.M Brown J.C Spivack N.W Fraser The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SLID mice J. Gen. Virol. 75 1994 2059 2063
79. T.M Lasner R Tal-Singer S Kesari V.M Lee J.Q Trojanowski N.W Fraser Toxicity and neuronal infection of a HSV1 ICP34.5 mutant in nude mice J. Neurovirol. 4 1998 100 105